Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Odacova Health is an evidence-led bionutrition platform company operating at the intersection of biotechnology and companion animal health. The company is developing MHCR-1, a proprietary, naturally derived botanical bioactive platform designed to translate the biology of calorie restriction into a practical healthy-aging solution for pets without requiring dietary restriction. Backed by a nine-year longitudinal canine research program, Odacova's science demonstrates positive impacts on molecular, metabolic, and functional aging markers, including gene expression, glucose regulation, and muscle power. Rather than building a consumer brand, Odacova operates on a B2B model focused on commercial licensing and strategic integrations across supplements, functional treats, and pet food.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Odacova Health.